Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Biosimilars

Pharmacists have good understanding of biosimilars but concerns over switching, study results show

Pharmacists have the greatest knowledge of biosimilars across surveyed healthcare professionals but share concerns about the safety and efficacy of switching patients to the medicines.

 

Lantus Insulin glargine injection soloution cartridges

Source: Alamy

Researchers found that pharmacists had the greatest knowledge and awareness of biosimilars with 84.8% being able to accurately define them, compared with 76.6% of consultants/registrars and 53.4% of nurses

UK pharmacists have a high level of understanding of biosimilars but have concerns about the safety and efficacy of switching patients to the drugs, research has shown[1].

The study, published in the International Journal of Pharmacy Practice (30 August 2018), involved a web-based survey completed by 150 medical consultants/registrars, 58 nurses and 26 pharmacists specialising in dermatology, diabetes, gastroenterology or rheumatology. The survey asked about their knowledge and experience of infliximab and insulin glargine biosimilars.

The results showed that pharmacists had the greatest knowledge and awareness of biosimilars, with 84.8% who could accurately define them, compared with 76.6% of consultants/registrars and 53.4% of nurses.

Concerns about safety and efficacy when switching patients to biosimilars were high among all the healthcare professionals, but nurses had a higher level of major concerns than doctors and pharmacists about the safety and efficacy of biosimilars when initiating them in biologic-naive patients.

The researchers said that as more biosimilars become available, knowledge gaps will likely arise among healthcare professionals.

“There is a variance in the level of understanding and attitude to biosimilars between professions, with a good level of understanding in medical consultants and pharmacists, but a lower level for nurses,” they said. 

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205528

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £133.00Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £252.00Buy now
  • Nurse Prescribers' Formulary

    Nurse Prescribers' Formulary

    Essential reference for Community Practitioner Nurse Prescribers. Provides an overview of common conditions and details of medicines that may be prescribed.

    £17.99Buy now
  • Martindale: The Complete Drug Reference

    Martindale: The Complete Drug Reference

    Martindale: The Complete Drug Reference provides reliable, unbiased and evaluated information on drugs and medicines used throughout the world.

    £570.00Buy now
  • Introduction to Clinical Pharmaceutics (An)

    Introduction to Clinical Pharmaceutics (An)

    This unique textbook covers the role of basic pharmaceutics in clinical outcomes and in explaining the behaviour of medicines in the body.

    £27.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.